A simple combination of serum type IV collagen and prothrombin time to diagnose cirrhosis in patients with chronic active hepatitis C

Hepatology Research

Volumn 30, Issue 4, 2004, Pages 214-220

  Qiu, Yi ^a   Hoshida, Yujin ^a   Kato, Naoya ^a   Moriyama, Masaru ^a   Otsuka, Motuyuki ^a   Taniguchi, Hiroyoshi ^a   Kawabe, Takao ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bootstrap; Cirrhosis; Diagnosis; Hepatitis C; ROC curve; Type IV collagen

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; COLLAGEN TYPE 4; GAMMA GLUTAMYLTRANSFERASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CHRONIC ACTIVE HEPATITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTHROMBIN TIME; ROC CURVE; THROMBOCYTE COUNT;

EID: 10944230779     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2004.10.006     Document Type: Article

References (19)

1. X. Forns S. Ampurdanes J.M. Sanchez-Tapias et al. Long-term follow up of chronic hepatitis C in patients diagnosed at a tertiary-care center J Hepatol 35 2001 265-271
2. S. Saadeh G. Cammell W.D. Carey Z. Younossi D. Barnes K. Easley The role of liver biopsy in chronic hepatitis C Hepatology 33 2001 196-200
3. F. Imbert-Bismut V. Ratziu L. Pieroni F. Charlott Y. Benhamou T. Poynard For the MULTIVIRC group Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study Lancet 357 2001 1069-1075
4. R.P. Myers M.H. Tainturier V. Ratziu et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B J Hepatol 39 2003 222-230
5. X. Forns S. Ampurdanes J.M. Llovet et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 2002 986-992
6. C.T. Wai J.K. Greenson R.J. Fontana et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518-526
7. H. Saito S. Tada N. Nakamoto et al. Efttcacy of non-invasive elastometry on staging of hepatic fibrosis Hepatol Res 29 2004 97-103
8. H. Kumada Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma Oncology 62 Suppl. 1 2002 94-100
9. E. Ono Y. Shiratori T. Okudaira M. Omata Platelet count reflects stage of chronic hepatitis C Hepatol Res 15 1999 192-200
10. V.J. Desmet M. Gerber J.H. Hoofnagle M. Manns P.J. Scheuer Classification of chronic hepatitis: Diagnosis, grading and staging Hepatology 19 1994 1513-1520
11. F.Y. Hsieh D.A. Bloch M.D. Larsen A simple method of size calculation for linear and logistic regression Stat Med 17 1998 1623-1634
12. J.A. Hanley B.J. McNeil A method of comparing the areas under receiver operating chraracteristic curves derived from the same cases Radiology 148 1983 839-843
13. A.C. Davison D.V. Hinkley Bootstrap Methodsand Their Applications 1997 Cambridge University Press
14. H. Yoshida Y. Shiratori M. Moriyama et al. Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy Ann Intern Med 131 1999 174-181
15. H. Yoshida R. Tateishi Y. Arakawa et al. Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C Gut 53 2004 425-430
16. K. Murawaki Y. Ikuta M. Koda S. Yamada Comparison of serum 7S fragment of type IV collagen and serum central triplw-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease J Hepatol 24 1996 148-154
17. K.M. Walsh A. Fletcher R.N.M. MacSween Basement membrane peptide as markers of liver disease in chronic hepatitis C J Hepatol 32 2000 325-330
18. C. Hirayama H. Suzuki A. Takada K. Fujisawa K. Tanikawa S. Igarashi Serum type IV collagen in various liver disease in comparison with serum 7S collagen, laminin, and type III procollagen peptide J Gastroenterol 31 1996 242-248
19. T. Ueno S. Inuzuka T. Torimura et al. Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen Scand J Gastroenterol 27 1992 513-520